Led by Legend Capital, Macrolux Completes Nearly CNY100 million Series A Round Feb 16, 2023 17:09 HKT |  |
|
Innovation is the Key Benchmark, Focus on Four Healthcare Industry Sub-Sectors in 2023, Says Jafar Wang of Legend Capital Feb 15, 2023 18:58 HKT |  |
|
The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar Feb 15, 2023 09:00 HKT |  |
|
Ocumension Therapeutics Issues Positive Profit Alert for 2022 Annual Results Feb 14, 2023 10:57 HKT |  |
|
EC Healthcare Announced Strategic Alliance with Prudential Feb 13, 2023 19:09 HKT |  |
|
First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases Feb 10, 2023 21:06 HKT |  |
|
Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific Feb 10, 2023 19:00 HKT |  |
|
Asia Pacific Cell & Gene Research Growing 50% Faster than ROW Feb 03, 2023 13:00 HKT |  |
|
Ocumension Therapeutics Announces The Completion Of The Phase I Clinical Trial Of Its Class I New Drug For The Treatment Of Dry Eye -- OT-202 Feb 03, 2023 10:01 HKT |  |
|
Ocumension Therapeutics Announces Its Patient Enrollment Completed In The Phase III Clinical Trail Of OT-101 In China Feb 01, 2023 10:00 HKT |  |
|
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating Jan 26, 2023 12:16 HKT |  |
|
Novotech Acquires US-based Drug Development Consulting Firm, CBR International Jan 12, 2023 15:00 HKT |  |
|
Novotech Acquires European CRO, Strengthens Global Operations Jan 12, 2023 15:00 HKT |  |
|
HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study) Jan 11, 2023 21:00 HKT |  |
|
Avance Clinical Celebrates GlobalReady Success as 40 Biotechs Join Program Jan 11, 2023 15:00 HKT |  |
|
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors Jan 11, 2023 11:19 HKT |  |
|
China Biotech Services subsidiary AMDL nominated as Top Clinical Laboratory Services Company in APAC 2022 and receives CAP Accreditation Certificate Jan 10, 2023 16:33 HKT |  |
|
Malaysian Genomics Explores R&D Collaboration with SIRIM Jan 09, 2023 14:00 HKT |  |
|
HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations Jan 05, 2023 18:00 HKT |  |
|
Sihuan Pharmaceutical (0460.HK): Huisheng Biopharmaceutical Successfully Completes A+ Round of Financing, Accelerating the Layout of Diabetes and Complications Jan 04, 2023 09:55 HKT |  |
|